HomeNEU • ASX
Follow
Neuren Pharmaceuticals Ltd
Previous close
$20.77
Day range
$20.70 - $21.43
Year range
$10.02 - $25.95
Market cap
2.71B AUD
Avg Volume
680.11K
P/E ratio
17.17
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 84.51M | 996.30% |
Operating expense | 1.13M | 217.18% |
Net income | 54.64M | 1,409.75% |
Net profit margin | 64.65 | 37.70% |
Earnings per share | — | — |
EBITDA | 75.56M | 2,185.78% |
Effective tax rate | 29.73% | — |
Balance Sheet
Total assets
Total liabilities
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 228.54M | 468.79% |
Total assets | 247.97M | 473.12% |
Total liabilities | 42.76M | 2,448.45% |
Total equity | 205.21M | — |
Shares outstanding | 127.27M | — |
Price to book | 12.90 | — |
Return on assets | 76.17% | — |
Return on capital | 92.04% | — |
Cash Flow
Net change in cash
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 54.64M | 1,409.75% |
Cash from operations | 70.02M | 1,387.49% |
Cash from investing | -105.73M | -2,349,533.33% |
Cash from financing | 1.26M | — |
Net change in cash | -10.65M | -334.22% |
Free cash flow | 48.16M | 1,840.73% |
About
CEO
Founded
2001
Website
Employees
8